Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure

Table 3

Diagnostic accuracy of serum suPAR level at admission for predicting 3-month mortality in HB-ACLF patients.

Cut-off point	Total ()	Nonsurvivors ()	Survivors ()	Se (%)	Sp (%)	PPV (%)	NPV (%)
>16.26 ng/ml	54	39	15	60.93	85.44	72.22	77.88	≤0.001
≤16.26 ng/ml	113	25	88

: number; Se: sensitivity; Sp: specificity; PPV: positive predictive value; NPV: negative predictive value.